Dr. Ruben Mesa, MD, director of the Mays Cancer Center, says racial and ethnic disparities in cancer clinical trials impact diagnostics and treatment of minority populations and explains the importance of diversity in clinical trials.
Newsroom
Dr. Ruben Mesa, MD, director of the Mays Cancer Center, says racial and ethnic disparities in cancer clinical trials impact diagnostics and treatment of minority populations and explains the importance of diversity in clinical trials.